The AHA today responded to a Department of Health and Human Services request for input from health care providers and other stakeholders on ensuring legitimate access to controlled substances, including opioids, while preventing diversion and abuse. The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 calls for HHS’ Office of the Assistant Secretary for Planning and Evaluation to submit a report to Congress on the issue. Among other actions, AHA recommends providing additional support for medical education, training and guidance for non-opioid pain management as well as for state drug courts, which offer justice-involved individuals with substance use disorders the opportunity to enter treatment programs.

Related News Articles

Despite what they say about gridlock and nothing going on in Washington, there actually is a lot going on in real time that has a real impact on ou
The American Organization of Nursing Leadership has chosen as its 2020 president-elect Erik Martin, vice president of patient care services and chief nursing…
House Democratic leaders today released the Lower Drug Costs Now Act, a bill that would make a series of changes to the Medicare program in an effort to lower…
The AHA today expressed concerns with the Fairness for High-Skilled Immigrants Act (S. 386/H.R.1044), legislation that would eliminate the per-country cap for…
Reps. Eliot Engel, D-N.Y., and Larry Bucshon, R-Ind., have introduced the Advancing Education on Biosimilars Act of 2019, which would create federal programs…
AHA featured in numerous media publications.